Cargando…
Metformin alleviates adriamycin resistance of osteosarcoma by declining YY1 to inhibit MDR1 transcriptional activity
Chemotherapy resistance hinders the successful treatment of osteosarcoma (OS) to some extent. Previous studies have confirmed that metformin (Met) enhances apoptosis induced by chemotherapeutic drugs, but the underlying mechanism remains unclear. To establish adriamycin (ADM)-resistant MG-63 (MG-63/...
Autores principales: | Wu, Bowen, Li, Peng, Qiu, Eryue, Chen, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571298/ https://www.ncbi.nlm.nih.gov/pubmed/37828612 http://dx.doi.org/10.1186/s40360-023-00685-8 |
Ejemplares similares
-
Silencing of ETS1 reverses adriamycin resistance in MCF-7/ADR cells via downregulation of MDR1
por: Wei, Jinrong, et al.
Publicado: (2014) -
The Why of YY1: Mechanisms of Transcriptional Regulation by Yin Yang 1
por: Verheul, Thijs C. J., et al.
Publicado: (2020) -
Hyperoside alleviates adriamycin-induced podocyte injury via inhibiting mitochondrial fission
por: Chen, Zhuyun, et al.
Publicado: (2017) -
YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma
por: Nigris, Filomena de, et al.
Publicado: (2011) -
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells
por: Li, Yangling, et al.
Publicado: (2017)